Randomized Study to Compare Immunogenicity and Safety of Seqirus* Quadrivalent Inactivated Influenza Vaccine With a US-Registered Influenza Vaccine in Pediatric Subjects Aged 5 to 17 Years
Open Forum Infectious Diseases（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要